TY - JOUR
T1 - Management of HIV infection in patients with substance use problems
AU - Nijhawan, Ank
AU - Kim, Soyun
AU - Rich, Josiah D.
N1 - Funding Information:
This work was made possible, in part, through the support of grant number P30-AI-42853 from the National Institutes of Health, Center for AIDS Research (NIH/ CFAR), grant numbers 5T32DA13911, RO1 DA 018641, and P30 DA013868 from the National Institute on Drug Abuse, National Institutes of Health (NIDA/NIH), and grant number 6H79TI14562 from the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment (SAMHSA/CSAT).
PY - 2008
Y1 - 2008
N2 - Although highly active antiretroviral therapy (HAART) has greatly reduced overall morbidity and mortality in patients with HIV, patients with substance use issues have been less likely than other patients with HIV to realize these benefits. Social obstacles (eg, lack of housing, minimal social support), and medical comorbidities (eg, mental illness, hepatitis), complicate the management of this group of patients. Not only are drug and alcohol users less likely to access medical care, initiation of HAART may be delayed due to concerns for adherence and the potential development of drug resistance. Ultimately, a multidisciplinary comprehensive approach is needed to both engage and retain this population in care. Through the integration of case management, addiction therapy, and medical treatment of HIV, we may be able to improve out-comes for patients with HIV and addiction.
AB - Although highly active antiretroviral therapy (HAART) has greatly reduced overall morbidity and mortality in patients with HIV, patients with substance use issues have been less likely than other patients with HIV to realize these benefits. Social obstacles (eg, lack of housing, minimal social support), and medical comorbidities (eg, mental illness, hepatitis), complicate the management of this group of patients. Not only are drug and alcohol users less likely to access medical care, initiation of HAART may be delayed due to concerns for adherence and the potential development of drug resistance. Ultimately, a multidisciplinary comprehensive approach is needed to both engage and retain this population in care. Through the integration of case management, addiction therapy, and medical treatment of HIV, we may be able to improve out-comes for patients with HIV and addiction.
UR - http://www.scopus.com/inward/record.url?scp=63249115445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63249115445&partnerID=8YFLogxK
U2 - 10.1007/s11908-008-0068-x
DO - 10.1007/s11908-008-0068-x
M3 - Review article
C2 - 18687208
AN - SCOPUS:63249115445
SN - 1523-3847
VL - 10
SP - 432
EP - 438
JO - Current Infectious Disease Reports
JF - Current Infectious Disease Reports
IS - 5
ER -